1. 743 High levels of stromal tumor infiltrating lymphocytes, CD3, CD8 cells & Immunoscore® are associated with pathological CR and time to progression in TNBC patients undergoing neo-adjuvant chemotherapy. (9th November 2020) Authors: Rapoport, Bernardo; Galon, Jérôme; Nayler, Simon; Fugon, Aurelie; Boquet, Isabelle; Martel, Marine; Mlecnik, B; Smit, Teresa; Benn, Carol Ann; Moosa, Farhana; Heyman, Liezl; Anderson, Ronald Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 743 High levels of stromal tumor infiltrating lymphocytes, CD3, CD8 cells & Immunoscore® are associated with pathological CR and time to progression in TNBC patients undergoing neo-adjuvant chemotherapy. (9th November 2020) Authors: Rapoport, Bernardo; Galon, Jérôme; Nayler, Simon; Fugon, Aurelie; Boquet, Isabelle; Martel, Marine; Mlecnik, B; Smit, Teresa; Benn, Carol Ann; Moosa, Farhana; Heyman, Liezl; Anderson, Ronald Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 7 (July 2022) Authors: Antoniotti, Carlotta; Rossini, Daniele; Pietrantonio, Filippo; Catteau, Aurélie; Salvatore, Lisa; Lonardi, Sara; Boquet, Isabelle; Tamberi, Stefano; Marmorino, Federica; Moretto, Roberto; Ambrosini, Margherita; Tamburini, Emiliano; Tortora, Giampaolo; Passardi, Alessandro; Bergamo, Francesca; Kas... Journal: Lancet oncology Issue: Volume 23:Issue 7(2022) Page Start: 876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗